Serum kynurenic acid positively correlates with cardiovascular disease risk factor, homocysteine: a study in stroke patients.

作者: Jarosław Pniewski , Radosław Woźniak , Ewa M Urbańska , Jerzy Lazarewicz , Elzbieta Luchowska

DOI:

关键词:

摘要: KYNA, an antagonist of ionotropic glutamate receptors and alpha7 nicotinic receptors, has been found as well in the brain periphery. The altered metabolism especially its deficiency, can lead to enhanced glutamate-mediated excitotoxicity, was suggested be a factor contributing development neurodegeneration seizures. Elevated serum concentration homocysteine is considered independent risk atherosclerosis emerging cognitive dysfunction stroke. In present study, level other biochemical parameters were assessed patients at early (up 24 h after infarct) stage Serum KYNA levels similar control (N = 26) stroke 24) groups. correlated positively with group, p 0.018; r 0.462 0.027; 0.451, respectively. also age (p 0.007; 0.514) creatinine 0.002; 0.581). 0.001; 0.644) urea < 0.716). Homocysteine inversely folate 0.01; -0.499) but not group 0.13; -0.317). 0.6401), 0.017; 0.4813). Clinical significance association between requires further investigation.

参考文章(32)
T Noguchi, Y Minatogawa, E Okuno, M Nakatani, M Morimoto, R Kido, Purification and characterization of kynurenine-2-oxoglutarate aminotransferase from the liver, brain and small intestine of rats Biochemical Journal. ,vol. 151, pp. 399- 406 ,(1975) , 10.1042/BJ1510399
Miguel Á. Medina, José L. Urdiales, María I. Amores-Sánchez, Roles of homocysteine in cell metabolism: old and new functions. FEBS Journal. ,vol. 268, pp. 3871- 3882 ,(2001) , 10.1046/J.1432-1327.2001.02278.X
Adam Splaver, Gervasio A Lamas, Charles H Hennekens, Homocysteine and cardiovascular disease: biological mechanisms, observational epidemiology, and the need for randomized trials. American Heart Journal. ,vol. 148, pp. 34- 40 ,(2004) , 10.1016/J.AHJ.2004.02.004
D. J. Meiklejohn, M. A. Vickers, R. Dijkhuisen, M. Greaves, Plasma Homocysteine Concentrations in the Acute and Convalescent Periods of Atherothrombotic Stroke Stroke. ,vol. 32, pp. 57- 62 ,(2001) , 10.1161/01.STR.32.1.57
Konrad Rejdak, Halina Bartosik-Psujek, Beata Dobosz, Tomasz Kocki, Paweł Grieb, Gavin Giovannoni, Waldemar A Turski, Zbigniew Stelmasiak, None, Decreased level of kynurenic acid in cerebrospinal fluid of relapsing-onset multiple sclerosis patients. Neuroscience Letters. ,vol. 331, pp. 63- 65 ,(2002) , 10.1016/S0304-3940(02)00710-3
T. Ogawa, W. R. Matson, M. F. Beal, R. H. Myers, E. D. Bird, P. Milbury, S. Saso, Kynurenine pathway abnormalities in Parkinson's disease Neurology. ,vol. 42, pp. 1702- 1702 ,(1992) , 10.1212/WNL.42.9.1702
E. Luchowska, P. Luchowski, R. Paczek, A. Ziembowicz, T. Kocki, W.A. Turski, M. Wielosz, J. Lazarewicz, E.M. Urbanska, Dual effect of DL-homocysteine and S-adenosylhomocysteine on brain synthesis of the glutamate receptor antagonist, kynurenic acid. Journal of Neuroscience Research. ,vol. 79, pp. 375- 382 ,(2005) , 10.1002/JNR.20359
Michiel L. Bots, Lenore J. Launer, Jan Lindemans, Arno W. Hoes, Albert Hofman, Jacqueline C. M. Witteman, Peter J. Koudstaal, Diederick E. Grobbee, Homocysteine and Short-term Risk of Myocardial Infarction and Stroke in the Elderly Archives of Internal Medicine. ,vol. 159, pp. 38- 44 ,(1999) , 10.1001/ARCHINTE.159.1.38
David Tanne, Moti Haim, Uri Goldbourt, Valentina Boyko, Ram Doolman, Yehuda Adler, Daniel Brunner, Solomon Behar, Ben-Ami Sela, Prospective Study of Serum Homocysteine and Risk of Ischemic Stroke Among Patients With Preexisting Coronary Heart Disease Stroke. ,vol. 34, pp. 632- 636 ,(2003) , 10.1161/01.STR.0000060203.58958.35
Rico Buchli, Daniela Alberati-Giani, Pari Malherbe, Christer Köhler, Clemens Broger, Andrea M. Cesura, Cloning and functional expression of a soluble form of kynurenine/alpha-aminoadipate aminotransferase from rat kidney. Journal of Biological Chemistry. ,vol. 270, pp. 29330- 29335 ,(1995) , 10.1074/JBC.270.49.29330